Literature DB >> 1432564

Toward the clarification of the construct of depersonalization and its association with affective and cognitive dysfunctions.

J R Jacobs1, G B Bovasso.   

Abstract

Little consensus or systematic research exists regarding the symptoms that constitute depersonalization and its association with affective and perceptual dysfunctions. A scale was constructed to measure depersonalization experiences reported in the literature and four items representing psychotic symptoms. Five factors representing different types of depersonalization emerged: Inauthenticity, Self-Negation, Self-Objectification, Derealization, and Body Detachment. Based on the factors, scales were constructed; these scales have internal consistency ranging from .78 to .84. Each of these factor scales was factorially distinguishable from psychosis and correlated between .48 and .58 with the Jackson and Messick (1972) Feelings of Unreality Scale, suggesting divergent and convergent validity. Inauthenticity, the most frequent and pervasive form of depersonalization experience, was best predicted by a cognitive style featuring intense, critical examination of self and others. In contrast, Self-Objectification was best predicted by thought disorganization and perceptual distortion and was experienced somewhat infrequently by relatively few subjects. All forms of depersonalization were associated with depression, except Inauthenticity.

Entities:  

Mesh:

Year:  1992        PMID: 1432564     DOI: 10.1207/s15327752jpa5902_11

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  2 in total

1.  Depersonalisation/derealisation symptoms in vestibular disease.

Authors:  F Yen Pik Sang; K Jáuregui-Renaud; D A Green; A M Bronstein; M A Gresty
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02-07       Impact factor: 10.154

2.  Validity and reliability of the Structured Clinical Interview for Depersonalization-Derealization Spectrum (SCI-DER).

Authors:  Marco Mula; Stefano Pini; Simona Calugi; Matteo Preve; Matteo Masini; Ilaria Giovannini; Ciro Conversano; Paola Rucci; Giovanni B Cassano
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.